PFIZER INC — Director's Dealing 2018

Feb 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2018-02-23

Reporting Person: Dolsten Mikael (President R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-24	Common Stock	M	174081.0000	$18.9000	Acquired	225265.0000	Direct
2018-02-24	Common Stock	F	53949.0000	$36.2600	Disposed	171316.0000	Direct
2018-02-24	Common Stock	F	55544.0000	$35.9800	Disposed	115772.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-23	Phantom Stock Units	$	I	16547.0000	Disposed		Common Stock (16547.0000)	Direct
2018-02-24	Stock Appreciation Rights	$18.9000	M	174081.0000	Disposed	2018-02-24	Common Stock (174081.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1573.0000	Indirect

Footnotes

F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F3: Price is the closing price of Pfizer common stock on February 23, 2018

F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

F6: Each unit represents one phantom share of common stock.

F7: The units, held under the Deferred Compensation Plan are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.